Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Publications

Objectives

Hyperketonemia (increased blood level of β-hydroxybutyrate or BHB) is a major metabolic disease in dairy cows negatively affecting animals’ health. A proper functioning of the energy metabolism (gluconeogenesis and Krebs-cycle) is essential to reduce the risk of hyperketonemia during post-partum period. For these reasons, hepato-protectors composed by precursors of energy metabolism pathways (as propionate, gluconeogenic amino acids (AA), vitamins and co-factors) are usually used in dairy cows during the transition period. A field study was performed to better characterize the efficacy of hepato-protectors to reduce the risk of hyperketonemia in dairy cows.

Materials and Methods

Animal care and procedures received ethical approval (n.204359/2023). A total of 445 Holstein-Friesian dairy cows were enrolled at the begging of the dry period, and randomly and equally divided into three groups: CTR (control without treatment); BOGERB (treated with Bograss® and Erbacolina PLUS®, CEVA Animal Health); MON (treated with monensin, Kexxtone). The BOG-ERB received 2 ml of Bograss®/10 kg BW, and 70 mL/animal/treatment of Erbacolina PLUS® at 12d before calving and 6d after calving; while the MON received 35.2 g/animal of monensin at 21d before calving. Blood sampling was performed at -21 and -7d before calving, at the day of calving, and at +7, +14, +28, and +55d after calving. All animals were evaluated for NEFA and BHB levels, while a complete biochemical analysis was performed for 45 animal per group (30 luriparous, and 15 primiparous). Differences in biochemical parameters were assessed with a linear mixed-effects model. A post hoc pairwise comparison was performed using Bonferroni correction. A logistic regression analysis was performed using blood BHB values (healthy, BHB<1.2 mmol/L; hyperketonemia, BHB≥1.2 mmol/L). The model considered the risk factors of treatment, time, parity, and season. A p-value<0.0532 was considered significant, whereas a 0.05≤p-value≤0.10 was considered a trend.

Results

Hyperketonemia prevalence in BOG-ERB group was between 2.9% to 11.1% during the post-partum period. In contrast, the prevalence was 6.1% to 24.1% in CTR, and was 5.3% to 16% in MON. In fact, the logistic regression identified for BOG-ERB an OR of 0.43 (CI: 0.3 to 0.8) compared to the CTR, and of 0.44 (CI: 0.1 to 0.8) compared to MON. The BOG-ERB cows showed the lower risk of hyperketonemia during the post-partum period considering a lowest level of NEFA from +7d to +28d, and BHB from +14d to +55d. Moreover, the CTR incurred in hypoglycemia at +7d. Regarding the liver, the AST and GGT concentrations were lowest in BOG-ERB from calving until the end of the study. The album in level was greatest in BOG-ERB from +14d to +55d in association with the lowest level of urea. Serum ALP concentration was greatest in BOG-ERB from -7d before calving to +55d associated with greater level of Ca up to +14d. Furthermore, serum Cl and Na were greater in the same group around calving. Regarding cows’ performances, the BOGERB had the greatest pregnancy/artificial insemination (BOG-ERB: 55.7; CTR: 49.8; MON: 49.9), and a greater milk production compared to CTR group without differences with MON group (BOG-ERB: 43±0.5 Kg/day; CTR: 42±0.5 Kg/day; MON: 43.5±0.5 Kg/day). Finally, the MON group produced more milk during the first 150 DIM, while the BOG-ERB produced more milk after 210 DIM.

Conclusions

Supporting animal metabolism through the use of hepato-protectors decreases lipomobilization, metabolic stress, and protein catabolism. This condition reduces the risk and prevalence of hyperketonemia during the post-partum period with greater reproductive performances and a more constant milk production the same group around calving. Regarding cows’ performances, the BOGERB had the greatest pregnancy/artificial insemination (BOG-ERB: 55.7; CTR: 49.8; MON: 49.9), and a greater milk production compared to CTR group without differences with MON group (BOG-ERB: 43±0.5 Kg/day; CTR: 42±0.5 Kg/day; MON: 43.5±0.5 Kg/day). Finally, the MON group produced more milk during the first 150 DIM, while the BOG-ERB produced more milk after 210 DIM.

Share this publication:

Publication file:

Download publication
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.